Vireo Growth (VREOF) Receivables (2020 - 2026)
Vireo Growth (VREOF) reported Receivables of $2.0 million for Q1 2026, down 17.51% on a YoY basis from $2.4 million in Q1 2025, and down 84.25% sequentially from $12.7 million in Q4 2025.
Vireo Growth (VREOF) Receivables (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Receivables data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 17.51% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 17.51% YoY), and the FY2025 full-year result was $12.7 million, up 317.1% from the prior year.
- Receivables slipped to $2.0 million in Q1 2026, from $12.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $12.7 million in Q4 2025 to a low of $109649.0 in Q4 2022.
- A 5-year average of $4.4 million and a median of $3.6 million in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables tumbled 97.66% in 2022 and jumped 656.85% in 2023, its largest moves.
- Tracing VREOF's Receivables over 5 years: stood at $109649.0 in 2022, then surged by 656.85% to $829877.0 in 2023, then surged by 266.9% to $3.0 million in 2024, then surged by 317.1% to $12.7 million in 2025, then slumped by 84.25% to $2.0 million in 2026.
- Business Quant data shows VREOF's Receivables at $2.0 million in Q1 2026, $12.7 million in Q4 2025, and $988641.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 988,641.00 |
| Jun 30, 2025 | 9.14 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Mar 31, 2024 | 5.13 Mn |
| Dec 31, 2023 | 829,877.00 |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 109,649.00 |
| Sep 30, 2022 | 859,103.00 |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 975,205.00 |
| Jun 30, 2021 | 2.31 Mn |